Distinguishing atrial fibrillation from sinus rhythm using commercial pulse detection systems: The non-interventional BAYathlon study

Christian Müller, Ulf Hengstmann, Michael Fuchs, Martin Kirchner, Frank Kleinjung, Harald Mathis, Stephan Martin, Ingo Bläse, Stefan Perings, Christian Müller, Ulf Hengstmann, Michael Fuchs, Martin Kirchner, Frank Kleinjung, Harald Mathis, Stephan Martin, Ingo Bläse, Stefan Perings

Abstract

Objective: Early diagnosis of atrial fibrillation (AFib) is a priority for stroke prevention. We sought to test four commercial pulse detection systems (CPDSs) for ability to distinguish AFib from normal sinus rhythm using a published algorithm (Zhou et al., PLoS One 2015;10:e0136544), compared with visual diagnosis by electrocardiogram inspection.

Methods: BAYathlon was a prospective, non-interventional, single-centre study. Adult cardiology patients with documented AFib or sinus rhythm who were due to have a routine 5-min electrocardiogram were randomized to undergo a parallel 5-min pulse assessment with a Polar V800, eMotion Faros 360, TomTom heart rate monitor, or Adidas miCoach Smart Run.

Results: 144 patients (73 with AFib, 71 with sinus rhythm (based on electrocardiograms); median age: 73 years; 53.5% male) were analysed. Algorithm sensitivities (primary endpoint) and specificities for AFib when applied to CPDS recordings were 93.3% and 94.1% with the Polar V800, 90.0% and 84.2% with the eMotion Faros 360, and 0% and 100% with the other CPDSs (analysis period: 127 heart rate signals + 2 min). When applied to routine electrocardiograms, the algorithm correctly detected AFib in 71/73 patients. Different analysis periods (127 heart rate signals +1 or 3 min) only slightly changed the sensitivities with the Polar V800 and eMotion Faros 360 and had no effect on the sensitivities with the other CPDSs.

Conclusion: AFib screening using the applied algorithm is feasible with the Polar V800 and eMotion Faros 360 (which provide RR interval data) but not with the other CPDSs (which provide pre-processed heart rate time series).ClinicalTrials.gov identifier: NCT02875106.

Keywords: Atrial fibrillation; algorithms; electrocardiography; observational study; sensitivity; sinus rhythm.

Conflict of interest statement

Declaration of conflicting interests: CM and MK are employees of Bayer Vital GmbH (Leverkusen, Germany). UH is an employee of Bayer AG (Leverkusen, Germany). CM and UH are inventors for a patent application of the BAYathlon app on behalf of Bayer AG (not yet granted). MF has no relationships relevant to the content of this paper to disclose. FK is an employee of Bayer AG (Berlin, Germany). SM received consultancy fees from Bayer Vital GmbH. HM and IB have no relationships with industry that might pose a conflict of interest in connection with the submitted article. SP is Editor-in-Chief of www.kardiologie.org which is partly sponsored by Bayer Vital GmbH.

© The Author(s) 2021.

Figures

Figure 1.
Figure 1.
Parallel assessment by routine electrocardiogram and a commercial pulse detection system. Patients underwent parallel assessment by routine electrocardiogram and a commercial pulse detection system (the Polar V800 in this example) for 5 minutes.
Figure 2.
Figure 2.
Overview of data processing steps. Patients with AFib or sinus rhythm underwent parallel assessment by routine ECG and one of four commercial pulse detection systems. Data were analysed using the AFib detection algorithm of Zhou et al. aData from these devices are already delivered as HR time series. bMoving average RR intervals over different window sizes were calculated from Polar V800 and eMotion Faros 360 data in patients with AFib (diagnosed by the investigator based on the routine ECG) to explore the effect of data pre-processing on the function of the algorithm. AFib: atrial fibrillation; ECG: electrocardiogram; HR: heart rate; HRM: heart rate monitor; OSEA-4-Java: open source ECG analysis software for Java (Version 1.0.0, https://github.com/MEDEVIT/OSEA-4-Java. ); tRR: RR intervals.
Figure 3.
Figure 3.
Patient disposition. Of 163 patients who were screened, 161 were enrolled and 144 were analysed. aRoutine ECG data obtained during the study were visually reviewed by the investigator to determine a diagnosis of AFib or sinus rhythm. AFib: atrial fibrillation; CPDS: commercial pulse detection system; ECG: electrocardiogram.
Figure 4.
Figure 4.
(a)–(b) ECGs from two patients with AFib who were incorrectly classified by the algorithm based on their routine ECG data, and (c) a Poincaré plot of correctly detected AFib. The ECGs and Poincaré plots of the two incorrectly classified patients showed (a) and (d) pseudo-arrhythmic AFib and (b) and (e) AFib with partly regular transition. AFib: atrial fibrillation; ECG: electrocardiogram.

References

    1. Kirchhof P, Benussi S, Kotecha D, et al.. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893–2962.
    1. Heijman J, Voigt N, Nattel S, et al.. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res 2014; 114: 1483–1499.
    1. Kirchhof P, Bax J, Blomstrom-Lundquist C, et al.. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ‘research perspectives in AF’. Eur Heart J 2009; 30: 2969–2977c.
    1. McConnell MV, Turakhia MP, Harrington RA, et al.. Mobile health advances in physical activity, fitness, and atrial fibrillation: moving hearts. J Am Coll Cardiol 2018; 71: 2691–2701.
    1. Mairesse GH, Moran P, Van Gelder IC, ESC Scientific Document Group et al.. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and sociedad latinoamericana de estimulacion cardiaca y electrofisiologia (SOLAECE). Europace 2017; 19: 1589–1623.
    1. Nieuwlaat R, Dinh T, Olsson SB, et al.. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 2008; 29: 915–922.
    1. Hohnloser SH, Pajitnev D, Pogue J, et al.. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy. J Am Coll Cardiol 2007; 50: 2156–2161.
    1. Giancaterino S, Lupercio F, Nishimura M, et al.. Current and future use of insertable cardiac monitors. JACC Clin Electrophysiol 2018; 4: 1383–1396.
    1. Giebel GD, Gissel C. Accuracy of mHealth devices for atrial fibrillation screening: systematic review. JMIR Mhealth Uhealth 2019; 7: e13641.
    1. Zhou X, Ding H, Wu W, et al.. A Real-Time atrial fibrillation detection algorithm based on the instantaneous state of heart rate. PLoS One 2015; 10: e0136544.
    1. Hamilton PS. Open source ECG analysis software documentation, (2002, accessed 26 August 2019).
    1. Kwiecien R, Kopp-Schneider A, Blettner M. Concordance analysis: part 16 of a series on evaluation of scientific publications. Dtsch Arztebl Int 2011; 108: 515–521.
    1. McManus DD, Chong JW, Soni A, et al.. PULSE-SMART: pulse-based arrhythmia discrimination using a novel smartphone application. J Cardiovasc Electrophysiol 2016; 27: 51–57.
    1. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174.
    1. Krummen DE, Feld GK, Narayan SM. Diagnostic accuracy of irregularly irregular RR intervals in separating atrial fibrillation from atrial flutter. Am J Cardiol 2006; 98: 209–214.
    1. Guo Y, Wang H, Zhang H, et al.. Mobile photoplethysmographic technology to detect atrial fibrillation. J Am Coll Cardiol 2019; 74: 2365–2375.
    1. Lown M, Yue AM, Shah BN, et al.. Screening for atrial fibrillation using economical and accurate technology (from the SAFETY study). Am J Cardiol 2018; 122: 1339–1344.
    1. Lown M, Yue A, Lewith G, et al.. Screening for Atrial Fibrillation using Economical and accurate TechnologY (SAFETY) – a pilot study. BMJ Open 2017; 7: e013535.
    1. Gillinov S, Etiwy M, Wang R, et al.. Variable accuracy of wearable heart rate monitors during aerobic exercise. Med Sci Sports Exerc 2017; 49: 1697–1703.
    1. Wang R, Blackburn G, Desai M, et al.. Accuracy of wrist-worn heart rate monitors. JAMA Cardiol 2017; 2: 104–106.
    1. Ayinde H, Schweizer ML, Crabb V, et al.. Age modifies the risk of atrial fibrillation among athletes: a systematic literature review and meta-analysis. Int J Cardiol Heart Vasc 2018; 18: 25–29.
    1. Li X, Cui S, Xuan D, et al.. Atrial fibrillation in athletes and general population: a systematic review and meta-analysis. Medicine (Baltimore) 2018; 97: e13405.

Source: PubMed

3
Suscribir